Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Privacy Policy  
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Articles /     
 
Can furosemide reduce the risk for sterile hemorrhagic cystitis due to cyclophosphamide?
Cyclophosphamide is a part of many chemotherapeutic protocols for dogs. Sterile hemorrhagic cystitis (SHC) due to this drug is a well-known side effect. Can the concurrent administration of furosemide reduce the risk?

In a retrospective study, 216 dogs with lymphoma that received cyclophosphamide chemotherapy in accordance with 1 of 2 protocols, with or without concurrent IV administration of furosemide, were examined. Data for the 2 groups were analyzed to determine the incidence and predisposing factors (age, breed, sex, weight, previous or preexisting disease, previous or preexisting urinary tract infection, neutropenia, azotemia, dose, and number of cyclophosphamide treatments) for cyclophosphamide-associated SHC.

Cyclophosphamide-associated SHC developed in 12 of 133 (9%) dogs that had not received concurrent administration of furosemide and cyclophosphamide treatments; of the 83 dogs that had received furosemide, only 1 (1.2%) developed SHC. Dogs receiving cyclophosphamide and furosemide concurrently were significantly less likely to develop SHC than dogs that did not receive furosemide. Dogs with previous or preexisting immune-mediated disease were significantly more likely to develop cyclophosphamide-associated SHC.

Analysis of results suggested an association between IV administration of furosemide concurrently with cyclophosphamide and decreased incidence of cyclophosphamide-associated SHC. Incidence of cyclophosphamide-associated SHC was similar in treated dogs that did not receive concurrent furosemide to that observed for other studies in which cyclophosphamide was administered orally.

Cyclophosphamide-associated SHC appeared to develop early during the course of chemotherapy when furosemide was not administered concurrently with cyclophosphamide.

Source: Charney, S.C.,Bergman, P.J., Hohenhaus, J.E., McKnight, J.A. (2003): Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990–1996). In: J Am Vet Med Assoc 2003;222: pp.1388–1393


Tell a friend   |   Print version   |   Send this article

ARTICLES

Acyclovir and Cyprinid herpesvirus 3 multiplication in vitromembers
Cyprinid herpesvirus 3 (CyHVâ€3), also known as koi herpesvirus (KHV), is an aetiological agent of a virulent and lethal disease in common and koi carp. In this study, the authors examined in vitro the antiâ€CyHVâ€3 activity of acyclovir (ACV), nucleoside analogue commonly used against human herpesviruses, as well as acyclovir monophospate (ACVâ€MP).

  • A novel herpesvirus associated with serious eye problems in a great horned owlmembers
  • Cerebrospinal Nematodiasis in Camelidsmembers
  • Peel meals as feed ingredients in poultry dietsmembers
  • Mycobacteria in aquarium fishmembers
  • Giardia duodenalis in primatesmembers
  • Architecture of extraocular muscles in hawks and owlsmembers
  • Leishmania spp. in Bats from an Area Endemic for Visceral Leishmaniasismembers
  • Pharmacokinetics of quinocetone in ducks after two routes of administrationmembers
  • Novel antibiotic treatment of zebrafish mycobacteriosismembers
  • Canine mammary tumours as model for hereditary breast cancer susceptibility genes in humansmembers
  • Treatment of corneal ulceration in stranded California sea lions members
  • Effects of substrates and stress on placental metabolismmembers


  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved